circREPS2 suppresses the progression of GC via miR-558/RUNX3/beta-catenin signaling and is a novel promising biomarker and target for GC treatment.
Circular RNA circREPS2 Acts as a Sponge of miR-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/beta-catenin Signaling.